OBJECTIVES: Currently used metrics for antibiotic utilization are not linked to a diagnosis and may be difficult to interpret. We aimed to describe patterns and variation in antibiotic management of three common infectious disease diagnoses in Veterans Affairs Medical Centers (VAMCs). METHODS: This descriptive retrospective cohort study included all veterans discharged between 2007 and 2009 after an acute care admission to a VAMC and a principal ICD-9-CM code for pneumonia (PNEU), skin and soft-tissue infections (SSTI), urinary tract infections (UTI) or non-infectious disease-related diagnoses (NON_INF). Systemic antibiotic use was assessed based on barcode medication administration data. A treatment period was defined as a time of uninterrupted inpatient antibiotic therapy with no gaps of >1 calendar day. RESULTS: Over the study period there were 1.44 million discharges with an acute care admission to 128 VAMCs included in the study. Of the discharges, 58 118 had a primary ICD-9-CM diagnosis classifiable as PNEU, 36 797 as SSTI, 30 223 as UTI and 1 243 098 as NON_INF. Empirical antibiotic use during the first 2 hospital days was frequent for all infectious disease diagnoses. Type of empirical coverage varied among facilities for all conditions, as did treatment durations. Roughly half of all empirical courses of therapy where the patient was still hospitalized on day 4 did not exhibit any change to the antibiotic regimen. CONCLUSIONS: There is substantial variation in the management of common infectious diseases with regard to choice of empirical agents and duration of therapy. Diagnosis-specific antibiotic use metrics may prove useful for antibiotic stewardship programmes.
OBJECTIVES: Currently used metrics for antibiotic utilization are not linked to a diagnosis and may be difficult to interpret. We aimed to describe patterns and variation in antibiotic management of three common infectious disease diagnoses in Veterans Affairs Medical Centers (VAMCs). METHODS: This descriptive retrospective cohort study included all veterans discharged between 2007 and 2009 after an acute care admission to a VAMC and a principal ICD-9-CM code for pneumonia (PNEU), skin and soft-tissue infections (SSTI), urinary tract infections (UTI) or non-infectious disease-related diagnoses (NON_INF). Systemic antibiotic use was assessed based on barcode medication administration data. A treatment period was defined as a time of uninterrupted inpatient antibiotic therapy with no gaps of >1 calendar day. RESULTS: Over the study period there were 1.44 million discharges with an acute care admission to 128 VAMCs included in the study. Of the discharges, 58 118 had a primary ICD-9-CM diagnosis classifiable as PNEU, 36 797 as SSTI, 30 223 as UTI and 1 243 098 as NON_INF. Empirical antibiotic use during the first 2 hospital days was frequent for all infectious disease diagnoses. Type of empirical coverage varied among facilities for all conditions, as did treatment durations. Roughly half of all empirical courses of therapy where the patient was still hospitalized on day 4 did not exhibit any change to the antibiotic regimen. CONCLUSIONS: There is substantial variation in the management of common infectious diseases with regard to choice of empirical agents and duration of therapy. Diagnosis-specific antibiotic use metrics may prove useful for antibiotic stewardship programmes.
Entities:
Keywords:
antibiotic use; infectious disease; practice variation
Authors: Alan E Gross; Trevor C Van Schooneveld; Keith M Olsen; Mark E Rupp; Thu Hong Bui; Elsie Forsung; Andre C Kalil Journal: Antimicrob Agents Chemother Date: 2014-06-23 Impact factor: 5.191
Authors: Christopher J Graber; Makoto M Jones; Matthew Bidwell Goetz; Karl Madaras-Kelly; Yue Zhang; Jorie M Butler; Charlene Weir; Ann F Chou; Sarah Y Youn; Matthew H Samore; Peter A Glassman Journal: Clin Infect Dis Date: 2020-08-22 Impact factor: 9.079
Authors: Haley J Appaneal; Aisling R Caffrey; Vrishali V Lopes; Christopher J Crnich; David M Dosa; Kerry L LaPlante Journal: Infect Control Hosp Epidemiol Date: 2019-07-29 Impact factor: 3.254
Authors: Barbara E Jones; Makoto M Jones; Benedikt Huttner; Gregory Stoddard; Kevin Antoine Brown; Vanessa W Stevens; Tom Greene; Brian Sauer; Karl Madaras-Kelly; Michael Rubin; Matthew Bidwell Goetz; Matthew Samore Journal: Clin Infect Dis Date: 2015-07-29 Impact factor: 9.079
Authors: Makoto Jones; Benedikt Huttner; Molly Leecaster; Angela Huttner; Kavitha Damal; Windy Tanner; Christopher Nielson; Michael A Rubin; Matthew Bidwell Goetz; Karl Madaras-Kelly; Matthew H Samore Journal: J Antimicrob Chemother Date: 2014-08-06 Impact factor: 5.790
Authors: Timothy C Jenkins; Bryan C Knepper; S Jason Moore; Sean T O'Leary; Carla C Saveli; Sean W Pawlowski; Daniel M Perlman; Bruce D McCollister; William J Burman Journal: Infect Control Hosp Epidemiol Date: 2014-08-20 Impact factor: 3.254
Authors: Theodoros Kelesidis; Nikolay Braykov; Daniel Z Uslan; Daniel J Morgan; Sumanth Gandra; Birgir Johannsson; Marin L Schweizer; Scott A Weisenberg; Heather Young; Joseph Cantey; Eli Perencevich; Edward Septimus; Arjun Srinivasan; Ramanan Laxminarayan Journal: Infect Control Hosp Epidemiol Date: 2015-10-12 Impact factor: 3.254
Authors: Jesse D Sutton; Ronald Carico; Muriel Burk; Makoto M Jones; XiangMing Wei; Melinda M Neuhauser; Matthew Bidwell Goetz; Kelly L Echevarria; Emily S Spivak; Francesca E Cunningham Journal: Open Forum Infect Dis Date: 2020-01-27 Impact factor: 3.835